The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
Clinical trial NCT01975389 · TERMINATED
Trial details
- NCT number
- NCT01975389
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-29
- Primary completion
- 2017-04-03
- Enrollment
- 10564
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.